Developing countries plant more GM crops than industrial countries

The United States remains the leading grower of biotech crops in the world but developing countries are fast catching up.

In the latest annual report of the International Service for the Acquisition of Agri-biotech Applications (ISAAA), which supports the commercialization of biotech products, 20 of the 28 countries that grow biotech crops are developing countries in Latin America, Africa and Asia including two South-East Asian nations.

“For the third consecutive year, developing countries planted more biotech crops than industrial countries,” said Rhodora Aldemita, ISAAA senior program officer who presented the report to Philippine media last 27 February in Makati City.

Developing countries now account for 96 million hectares of land planted to biotech crops, representing nearly 53 percent of the global total of 181.5 million hectares.

The US remains the largest grower of genetically modified crops in 2014 with 73.1 million hectares, roughly 40 percent of the total and with a declining percentage share. Brazil is second, with 42.2 million hectares. Argentina is third, followed by India, Canada and China.

In South-East Asian, the Philippines placed 12th in the global ranking, with 800,000 hectares planted to biotech maize, while Myanmar took the 15th spot, with 300,000 hectares for cotton.

Biotech is the fastest growing crop technology that has been adopted by 18 million farmers, says the report. In 2014, nine out of 10 of these farmers were small cultivators in developing countries. The adoption rate has seen a 100-fold increase since biotech crops were first planted in 1996.

Read full, original article: Developing nations now dominate GM crop production

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-10-12-at-10.44.38-AM
Widely condemned as unethical, hepatitis B vaccine study funded by RFK Jr’s CDC gets a final greenlight
Prescription Capsules Scattered on Twenty-Dollar Bills
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it, Part 2
newborn baby spit up gerd
Vaccine-preventable congenital infections are a leading driver of autism
Screenshot-2026-10-08-at-10.41.33-AM
Viewpoint: Wellness patches: Most vitamin supplements are useless and sometimes even dangerous, but this craze is even worse
Cross and Syringe Standoff
Viewpoint: Hijacking Jesus: How anti-vaccine fanatics are exploiting religious exemptions and killing children
Screenshot 2026-10-16 at 5.38
PFAS in Agriculture: Science, Uncertainty, and Risk Communication
Deepfake Democracy Media Mosaic
31 states have passed a patchwork of laws to limit election deepfake commercials. They’re not working very well.
Government Briefing on Autism Trends
Viewpoint: ‘Statistical murder’: Kennedy’s expanding record of “duplicity and mendacity”
Screenshot 2026-10-16 at 11.17
Viewpoint: Latest attack on renewable energy and farmers, new USDA rules could put solar grants out of reach for small producers
FDA Vials and Syringes Flat Lay
Online gold rush of unapproved peptides is outrunning federal regulators
generated-1790707585414
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.